DecisionPoint Financial’s Thermo Fisher Scientific TMO Stock Holding History

DecisionPoint Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.3K	Sell	22 -5	-19%	-$2.4K	﹤0.01%	193
2026 Q1	$13.3K	Hold	27	–	–	﹤0.01%	167
2025 Q4	$15.6K	Buy	27 +20	+286%	+$11.3K	﹤0.01%	160
2025 Q3	$3.72K	Hold	7	–	–	﹤0.01%	193
2025 Q2	$2.95K	Buy	+7	New	+$2.93K	﹤0.01%	206
2023 Q2	–	Sell	-20	Closed	-$11.5K	–	215
2023 Q1	$11.5K	Buy	+20	New	+$11.3K	0.01%	107

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DecisionPoint Financial's TMO Position: Q2 2026 in Review

DecisionPoint Financial reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q2 2026, selling an estimated $2.4K and leaving 22 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

DecisionPoint Financial first reported a position in TMO in Q1 2023 and has held it in 6 quarters since. The position peaked at $15.6K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

DecisionPoint Financial held 22 shares of Thermo Fisher Scientific worth $11.3K as of Q2 2026.
DecisionPoint Financial sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
Thermo Fisher Scientific made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #193 holding.
DecisionPoint Financial first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 6 quarters since.
DecisionPoint Financial's Thermo Fisher Scientific position peaked at $15.6K in Q4 2025.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.